Safety concerns about alosetron.
Camilleri
Michael
M
D002243:Carbolines / Q000009:adverse effects*; D017091:Colitis, Ischemic / Q000139:chemically induced*; D003248:Constipation / Q000139:chemically induced*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D011358:Product Surveillance, Postmarketing
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron